Outcomes Related to Bacterial Co-Infection and Antibiotic Use in Adults Hospitalized With Respiratory Syncytial Virus Compared with Influenza - Takeaways - MDSpire

Outcomes Related to Bacterial Co-Infection and Antibiotic Use in Adults Hospitalized With Respiratory Syncytial Virus Compared with Influenza

  • By

  • Kristine L Karlsen

  • Clara L Clausen

  • Ragda A S Kahiyah

  • Aymen Alkarawi

  • Amanda M Egeskov-Cavling

  • Noor Hayder

  • Adin Sejdic

  • Casper Roed

  • Jon G Holler

  • Lene Nielsen

  • Mads F Eiberg

  • Omid Rezahosseini

  • Christian Østergaard

  • Zitta B Harboe

  • Thea K Fischer

  • Birgitte Lindegaard

  • Thomas Benfield

  • December 18, 2025

  • 0 min

Share

  • 1

    Adults hospitalized with RSV have mortality risks comparable to or higher than those with influenza A or B.

  • 2

    Bacterial co-infections were present in approximately 23% of RSV, 25% of influenza A, and 28% of influenza B patients.

  • 3

    Antibiotic use within 48 hours was common among patients without bacterial co-infection across all virus groups.

  • 4

    Bacterial co-infection in RSV patients was not associated with increased mortality or adverse clinical outcomes.

  • 5

    Early antibiotic treatment was linked to prolonged length of stay but did not improve survival rates.

Original Source(s)

Related Content